These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 19622577

  • 1. Transcriptional repression and inhibition of nuclear translocation of androgen receptor by diallyl trisulfide in human prostate cancer cells.
    Stan SD, Singh SV.
    Clin Cancer Res; 2009 Aug 01; 15(15):4895-903. PubMed ID: 19622577
    [Abstract] [Full Text] [Related]

  • 2. D,L-Sulforaphane causes transcriptional repression of androgen receptor in human prostate cancer cells.
    Kim SH, Singh SV.
    Mol Cancer Ther; 2009 Jul 01; 8(7):1946-54. PubMed ID: 19584240
    [Abstract] [Full Text] [Related]

  • 3. Diallyl trisulfide inhibits activation of signal transducer and activator of transcription 3 in prostate cancer cells in culture and in vivo.
    Chandra-Kuntal K, Singh SV.
    Cancer Prev Res (Phila); 2010 Nov 01; 3(11):1473-83. PubMed ID: 20959517
    [Abstract] [Full Text] [Related]

  • 4. Garlic constituent diallyl trisulfide suppresses x-linked inhibitor of apoptosis protein in prostate cancer cells in culture and in vivo.
    Kim SH, Bommareddy A, Singh SV.
    Cancer Prev Res (Phila); 2011 Jun 01; 4(6):897-906. PubMed ID: 21411500
    [Abstract] [Full Text] [Related]

  • 5. Garlic constituent diallyl trisulfide prevents development of poorly differentiated prostate cancer and pulmonary metastasis multiplicity in TRAMP mice.
    Singh SV, Powolny AA, Stan SD, Xiao D, Arlotti JA, Warin R, Hahm ER, Marynowski SW, Bommareddy A, Potter DM, Dhir R.
    Cancer Res; 2008 Nov 15; 68(22):9503-11. PubMed ID: 19010926
    [Abstract] [Full Text] [Related]

  • 6. Honokiol inhibits androgen receptor activity in prostate cancer cells.
    Hahm ER, Karlsson AI, Bonner MY, Arbiser JL, Singh SV.
    Prostate; 2014 Apr 15; 74(4):408-20. PubMed ID: 24338950
    [Abstract] [Full Text] [Related]

  • 7. Diallyl trisulfide suppresses growth of PC-3 human prostate cancer xenograft in vivo in association with Bax and Bak induction.
    Xiao D, Lew KL, Kim YA, Zeng Y, Hahm ER, Dhir R, Singh SV.
    Clin Cancer Res; 2006 Nov 15; 12(22):6836-43. PubMed ID: 17121905
    [Abstract] [Full Text] [Related]

  • 8. Garlic constituent diallyl trisulfide induced apoptosis in MCF7 human breast cancer cells.
    Malki A, El-Saadani M, Sultan AS.
    Cancer Biol Ther; 2009 Nov 15; 8(22):2175-85. PubMed ID: 19823037
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Down-regulation of androgen receptor by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in both hormone-sensitive LNCaP and insensitive C4-2B prostate cancer cells.
    Bhuiyan MM, Li Y, Banerjee S, Ahmed F, Wang Z, Ali S, Sarkar FH.
    Cancer Res; 2006 Oct 15; 66(20):10064-72. PubMed ID: 17047070
    [Abstract] [Full Text] [Related]

  • 11. Mitochondria-mediated apoptosis by diallyl trisulfide in human prostate cancer cells is associated with generation of reactive oxygen species and regulated by Bax/Bak.
    Kim YA, Xiao D, Xiao H, Powolny AA, Lew KL, Reilly ML, Zeng Y, Wang Z, Singh SV.
    Mol Cancer Ther; 2007 May 15; 6(5):1599-609. PubMed ID: 17513609
    [Abstract] [Full Text] [Related]

  • 12. Repression of androgen receptor in prostate cancer cells by phenethyl isothiocyanate.
    Wang LG, Liu XM, Chiao JW.
    Carcinogenesis; 2006 Oct 15; 27(10):2124-32. PubMed ID: 16704988
    [Abstract] [Full Text] [Related]

  • 13. Capillarisin blocks prostate-specific antigen expression on activation of androgen receptor in prostate carcinoma cells.
    Tsui KH, Chang YL, Feng TH, Hou CP, Lin YH, Yang PS, Lee BW, Juang HH.
    Prostate; 2018 Mar 15; 78(4):242-249. PubMed ID: 29164633
    [Abstract] [Full Text] [Related]

  • 14. Indole-3-carbinol inhibition of androgen receptor expression and downregulation of androgen responsiveness in human prostate cancer cells.
    Hsu JC, Zhang J, Dev A, Wing A, Bjeldanes LF, Firestone GL.
    Carcinogenesis; 2005 Nov 15; 26(11):1896-904. PubMed ID: 15958518
    [Abstract] [Full Text] [Related]

  • 15. Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA).
    Lee SO, Yeon Chun J, Nadiminty N, Trump DL, Ip C, Dong Y, Gao AC.
    Prostate; 2006 Jul 01; 66(10):1070-5. PubMed ID: 16637076
    [Abstract] [Full Text] [Related]

  • 16. A novel androgen receptor antagonist JJ-450 inhibits enzalutamide-resistant mutant ARF876L nuclear import and function.
    Wu Z, Wang K, Yang Z, Pascal LE, Nelson JB, Takubo K, Wipf P, Wang Z.
    Prostate; 2020 Mar 01; 80(4):319-328. PubMed ID: 31868960
    [Abstract] [Full Text] [Related]

  • 17. A regulatory feedback loop between Ca2+/calmodulin-dependent protein kinase kinase 2 (CaMKK2) and the androgen receptor in prostate cancer progression.
    Karacosta LG, Foster BA, Azabdaftari G, Feliciano DM, Edelman AM.
    J Biol Chem; 2012 Jul 13; 287(29):24832-43. PubMed ID: 22654108
    [Abstract] [Full Text] [Related]

  • 18. Effect of diallyl trisulfide derivatives on the induction of apoptosis in human prostate cancer PC-3 cells.
    Chen M, Li B, Zhao X, Zuo H, He X, Li Z, Liu X, Chen L.
    Mol Cell Biochem; 2012 Apr 13; 363(1-2):75-84. PubMed ID: 22143535
    [Abstract] [Full Text] [Related]

  • 19. A novel synthetic compound that interrupts androgen receptor signaling in human prostate cancer cells.
    Lu S, Wang A, Lu S, Dong Z.
    Mol Cancer Ther; 2007 Jul 13; 6(7):2057-64. PubMed ID: 17620434
    [Abstract] [Full Text] [Related]

  • 20. Lupeol, a novel androgen receptor inhibitor: implications in prostate cancer therapy.
    Siddique HR, Mishra SK, Karnes RJ, Saleem M.
    Clin Cancer Res; 2011 Aug 15; 17(16):5379-91. PubMed ID: 21712449
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.